2 false false false false false false false false false false true false false false false false false No description of principal activity 2022-11-01 Sage Accounts Production Advanced 2023 - FRS102_2023 xbrli:pure xbrli:shares iso4217:GBP 11604672 2022-11-01 2023-10-31 11604672 2023-10-31 11604672 2022-10-31 11604672 2021-11-01 2022-10-31 11604672 2022-10-31 11604672 2021-10-31 11604672 bus:Director1 2022-11-01 2023-10-31 11604672 core:WithinOneYear 2023-10-31 11604672 core:WithinOneYear 2022-10-31 11604672 bus:Micro-entities 2022-11-01 2023-10-31 11604672 bus:AuditExemptWithAccountantsReport 2022-11-01 2023-10-31 11604672 bus:SmallCompaniesRegimeForAccounts 2022-11-01 2023-10-31 11604672 bus:PrivateLimitedCompanyLtd 2022-11-01 2023-10-31 11604672 bus:FullAccounts 2022-11-01 2023-10-31
COMPANY REGISTRATION NUMBER: 11604672
SV CLINICAL TRIALS LTD
Filleted Unaudited Financial Statements
31 October 2023
SV CLINICAL TRIALS LTD
Statement of Financial Position
31 October 2023
2023
2022
£
£
Current assets
179,679
65,771
Creditors: amounts falling due within one year
82,454
28,349
---------
--------
Net current assets
97,225
37,422
--------
--------
Total assets less current liabilities
97,225
37,422
Accruals and deferred income
4,637
1,834
--------
--------
92,588
35,588
--------
--------
Capital and reserves
92,588
35,588
--------
--------
Notes to the financial statements
1. Employee numbers
The average number of persons employed by the company during the year amounted to 2 (2022: 2 ).
2. Director's advances, credits and guarantees
For the year ending 31 October 2023 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
Director's responsibilities:
- The members have not required the company to obtain an audit of its financial statements for the year in question in accordance with section 476 ;
- The director acknowledges his responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of financial statements .
These financial statements have been prepared in accordance with the micro-entity provisions and have been delivered in accordance with the provisions applicable to companies subject to the small companies regime.
These financial statements were approved by the board of directors and authorised for issue on 29 October 2024 , and are signed on behalf of the board by:
Mr P Chetla
Director
Company registration number: 11604672
The company is a private company limited by shares, registered in England and Wales. The address of the registered office is 8 Oswald Street, Wellesley, Aldershot, GU11 4AP.